ORAL DOSAGE FORMS COMPRISING FENOFIBRATE - Patent 1517676

(19)

(11)

EP 1 517 676 A1

(12)

(43)	Date of publication:
	30.03.2005 Bulletin 2005/13

(21)	Application number: 03722005.0

(22)	Date of filing: 02.05.2003

(51)	International Patent Classification (IPC)⁷: A61K 9/20, A61K 9/16, A61K 31/216

(86)	International application number:
	PCT/US2003/013865

(87)	International publication number:
	WO 2003/092659 (13.11.2003 Gazette 2003/46)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

03.05.2002 US 377237 P

(71)	Applicant: SKYEPHARMA CANADA INC.
	Verdun,Québec H3E 1H4 (CA)

(72)	Inventors:
	VACHON, Michael Westmount, Québec H3Y 2X2 (CA) AWEDESH, Mishra K. Verdun, Québec H3E 1H8 (CA) SNOW, Robert, A. West Chester, PA 19380 (US) GUIVARC'H, Pol-Henri Montreal, Québec H3L 3C1 (CA)

(74)	Representative: Crump, Julian Richard John et al
	Mintz Levin Cohn Ferris Glovsky and PopeoIntellectual Property LLPThe Rectory9, Ironmonger Lane London EC2V 8EY London EC2V 8EY (GB)

(54)	ORAL DOSAGE FORMS COMPRISING FENOFIBRATE